![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: S100A11 |
Gene summary for S100A11 |
![]() |
Gene information | Species | Human | Gene symbol | S100A11 | Gene ID | 6282 |
Gene name | S100 calcium binding protein A11 | |
Gene Alias | HEL-S-43 | |
Cytomap | 1q21.3 | |
Gene Type | protein-coding | GO ID | GO:0006260 | UniProtAcc | P31949 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6282 | S100A11 | RNA-P7T1-P7T1-3 | Human | Lung | AIS | 1.68e-05 | 4.25e-01 | -0.0822 |
6282 | S100A11 | RNA-P7T1-P7T1-4 | Human | Lung | AIS | 1.13e-07 | 4.67e-01 | -0.0809 |
6282 | S100A11 | C04 | Human | Oral cavity | OSCC | 2.74e-42 | 5.71e+00 | 0.2633 |
6282 | S100A11 | C21 | Human | Oral cavity | OSCC | 4.98e-88 | 5.98e+00 | 0.2678 |
6282 | S100A11 | C30 | Human | Oral cavity | OSCC | 1.81e-79 | 6.56e+00 | 0.3055 |
6282 | S100A11 | C38 | Human | Oral cavity | OSCC | 3.07e-34 | 4.71e+00 | 0.172 |
6282 | S100A11 | C43 | Human | Oral cavity | OSCC | 1.14e-95 | 3.84e+00 | 0.1704 |
6282 | S100A11 | C46 | Human | Oral cavity | OSCC | 1.46e-68 | 4.09e+00 | 0.1673 |
6282 | S100A11 | C51 | Human | Oral cavity | OSCC | 2.18e-47 | 4.53e+00 | 0.2674 |
6282 | S100A11 | C57 | Human | Oral cavity | OSCC | 6.74e-83 | 4.66e+00 | 0.1679 |
6282 | S100A11 | C06 | Human | Oral cavity | OSCC | 5.64e-36 | 5.52e+00 | 0.2699 |
6282 | S100A11 | C07 | Human | Oral cavity | OSCC | 1.65e-30 | 4.93e+00 | 0.2491 |
6282 | S100A11 | C08 | Human | Oral cavity | OSCC | 7.59e-84 | 4.66e+00 | 0.1919 |
6282 | S100A11 | C86 | Human | Oral cavity | OSCC | 1.17e-28 | 3.34e+00 | 0.161 |
6282 | S100A11 | C09 | Human | Oral cavity | OSCC | 4.91e-65 | 3.70e+00 | 0.1431 |
6282 | S100A11 | LN22 | Human | Oral cavity | OSCC | 8.85e-70 | 4.30e+00 | 0.1733 |
6282 | S100A11 | LN38 | Human | Oral cavity | OSCC | 3.44e-82 | 4.07e+00 | 0.168 |
6282 | S100A11 | LN46 | Human | Oral cavity | OSCC | 1.78e-30 | 4.01e+00 | 0.1666 |
6282 | S100A11 | LP15 | Human | Oral cavity | LP | 8.98e-17 | 5.08e+00 | 0.2174 |
6282 | S100A11 | LP16 | Human | Oral cavity | LP | 7.39e-07 | 2.21e+00 | 0.1055 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00062602 | Cervix | CC | DNA replication | 48/2311 | 260/18723 | 2.70e-03 | 1.85e-02 | 48 |
GO:0006260 | Colorectum | MSI-H | DNA replication | 31/1319 | 260/18723 | 2.83e-03 | 3.63e-02 | 31 |
GO:0006275 | Colorectum | CRC | regulation of DNA replication | 21/2078 | 107/18723 | 6.56e-03 | 4.70e-02 | 21 |
GO:00149103 | Endometrium | AEH | regulation of smooth muscle cell migration | 19/2100 | 89/18723 | 4.12e-03 | 2.73e-02 | 19 |
GO:00149092 | Endometrium | AEH | smooth muscle cell migration | 20/2100 | 97/18723 | 5.00e-03 | 3.14e-02 | 20 |
GO:00062752 | Endometrium | AEH | regulation of DNA replication | 21/2100 | 107/18723 | 7.38e-03 | 4.20e-02 | 21 |
GO:000627511 | Endometrium | EEC | regulation of DNA replication | 22/2168 | 107/18723 | 5.09e-03 | 3.20e-02 | 22 |
GO:001491011 | Endometrium | EEC | regulation of smooth muscle cell migration | 19/2168 | 89/18723 | 5.83e-03 | 3.49e-02 | 19 |
GO:001490911 | Endometrium | EEC | smooth muscle cell migration | 20/2168 | 97/18723 | 7.11e-03 | 4.07e-02 | 20 |
GO:00062604 | Esophagus | ESCC | DNA replication | 181/8552 | 260/18723 | 3.55e-15 | 2.05e-13 | 181 |
GO:00062754 | Esophagus | ESCC | regulation of DNA replication | 73/8552 | 107/18723 | 1.97e-06 | 2.28e-05 | 73 |
GO:0014911 | Liver | NAFLD | positive regulation of smooth muscle cell migration | 11/1882 | 47/18723 | 5.92e-03 | 4.47e-02 | 11 |
GO:0014910 | Liver | NAFLD | regulation of smooth muscle cell migration | 17/1882 | 89/18723 | 6.91e-03 | 4.87e-02 | 17 |
GO:00062601 | Liver | HCC | DNA replication | 146/7958 | 260/18723 | 5.68e-06 | 7.02e-05 | 146 |
GO:00062751 | Liver | HCC | regulation of DNA replication | 60/7958 | 107/18723 | 3.15e-03 | 1.46e-02 | 60 |
GO:00149102 | Lung | IAC | regulation of smooth muscle cell migration | 19/2061 | 89/18723 | 3.35e-03 | 2.87e-02 | 19 |
GO:0014909 | Lung | IAC | smooth muscle cell migration | 20/2061 | 97/18723 | 4.05e-03 | 3.31e-02 | 20 |
GO:00149091 | Lung | AIS | smooth muscle cell migration | 19/1849 | 97/18723 | 2.74e-03 | 2.75e-02 | 19 |
GO:0014812 | Lung | AIS | muscle cell migration | 20/1849 | 110/18723 | 5.24e-03 | 4.49e-02 | 20 |
GO:00149101 | Lung | AIS | regulation of smooth muscle cell migration | 17/1849 | 89/18723 | 5.80e-03 | 4.83e-02 | 17 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
S100A11 | SNV | Missense_Mutation | c.211A>G | p.Ser71Gly | p.S71G | P31949 | protein_coding | tolerated(0.48) | benign(0.01) | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
S100A11 | SNV | Missense_Mutation | novel | c.104N>T | p.Ser35Phe | p.S35F | P31949 | protein_coding | deleterious(0.01) | probably_damaging(0.93) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
S100A11 | SNV | Missense_Mutation | c.74C>T | p.Ala25Val | p.A25V | P31949 | protein_coding | deleterious(0.02) | benign(0.194) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
S100A11 | SNV | Missense_Mutation | c.169N>T | p.Pro57Ser | p.P57S | P31949 | protein_coding | deleterious(0.01) | possibly_damaging(0.615) | TCGA-AX-A0J1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
S100A11 | SNV | Missense_Mutation | novel | c.34C>T | p.Arg12Trp | p.R12W | P31949 | protein_coding | tolerated(0.16) | benign(0.003) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
S100A11 | SNV | Missense_Mutation | novel | c.59N>C | p.Val20Ala | p.V20A | P31949 | protein_coding | deleterious(0) | probably_damaging(0.915) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
S100A11 | SNV | Missense_Mutation | c.8N>C | p.Lys3Thr | p.K3T | P31949 | protein_coding | deleterious_low_confidence(0) | benign(0.001) | TCGA-93-A4JQ-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
S100A11 | SNV | Missense_Mutation | novel | c.178C>T | p.Leu60Phe | p.L60F | P31949 | protein_coding | tolerated(0.06) | benign(0.423) | TCGA-CV-7104-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |